Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)

WC Black, A Abdoli, X An, A Auger… - Journal of Medicinal …, 2024 - ACS Publications
ATR is a key kinase in the DNA-damage response (DDR) that is synthetic lethal with several
other DDR proteins, making it an attractive target for the treatment of genetically selected …

DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies

M Kwok, A Agathanggelou, T Stankovic - Blood, 2024 - ashpublications.org
The DNA damage response (DDR) encompasses the detection and repair of DNA lesions
and is fundamental to the maintenance of genome integrity. Germ line DDR alterations …

Targeting TP53 disruption in chronic lymphocytic leukemia: Current strategies and future directions

S Molica, C Tam, D Allsup… - Hematological Oncology, 2024 - Wiley Online Library
In the modern era of Chronic Lymphocytic Leukemia (CLL) targeted therapy, the loss of p53
function due to genetic abnormalities remains a significant challenge. This is because even …